Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Reith

Showing results (201-210 of 233) with videos related to

Pageof 24
Sort By:
Clinical Journal of the American Society of Nephrology : CJASN|August 25, 2016
Use of Causal Diagrams to Inform the Design and Interpretation of Observational Studies: An Example from the Study of Heart and Renal Protection (SHARP)Natalie Staplin, William G Herrington, Parminder K Judge, et al.
Bioorganic & Medicinal Chemistry|May 12, 2009
Investigation of various N-heterocyclic substituted piperazine versions of 5/7-{[2-(4-aryl-piperazin-1-yl)-ethyl]-propyl-amino}-5,6,7,8-tetrahydro-naphthalen-2-ol: effect on affinity and selectivity for dopamine D3 receptorDennis A Brown, Manoj Mishra, Suhong Zhang, et al.
Journal of Medicinal Chemistry|October 1, 2004
Further structurally constrained analogues of cis-(6-benzhydrylpiperidin-3-yl)benzylamine with elucidation of bioactive conformation: discovery of 1,4-diazabicyclo[3.3.1]nonane derivatives and evaluation of their biological properties for the monoamine transportersRohit Kolhatkar, Charles D Cook, Sujit K Ghorai, et al.
Science (New York, N.Y.)|August 11, 2007
LeuT-desipramine structure reveals how antidepressants block neurotransmitter reuptakeZheng Zhou, Juan Zhen, Nathan K Karpowich, et al.
The Journal of Pharmacology and Experimental Therapeutics|August 16, 2018
Tamoxifen Directly Interacts with the Dopamine TransporterSarah R Mikelman, Bipasha Guptaroy, Kyle C Schmitt, et al.
Journal of Neurochemistry|June 22, 2011
SKF-83566, a D1-dopamine receptor antagonist, inhibits the dopamine transporterMelissa A Stouffer, Solav Ali, Maarten E A Reith, et al.
Neurochemical Research|January 1, 2016
Efficacy of Hybrid Tetrahydrobenzo[d]thiazole Based Aryl Piperazines D-264 and D-301 at D₂ and D₃ ReceptorsJuan Zhen, Tamara Antonio, Joanna C Jacob, et al.
Journal of Neurochemistry|August 9, 2020
SLC6 transporter oligomerizationKumaresan Jayaraman, Anand K Das, Dino Luethi, et al.
Cytometry|January 1, 1992
Comparison between flow cytometry and image cytometry in ploidy distribution assessments in gynecologic cancerJ Kaern, J Wetteland, C G Tropé, et al.
Molecular Psychiatry|October 15, 2021
The dopamine transporter gene SLC6A3: multidisease risksMaarten E A Reith, Sandhya Kortagere, Corinde E Wiers, et al.
Pageof 24

Showing results (201-210 of 233) with videos related to

Sort By:
Pageof 24
Clinical Journal of the American Society of Nephrology : CJASN|August 25, 2016
Use of Causal Diagrams to Inform the Design and Interpretation of Observational Studies: An Example from the Study of Heart and Renal Protection (SHARP)Natalie Staplin, William G Herrington, Parminder K Judge, et al.
Bioorganic & Medicinal Chemistry|May 12, 2009
Investigation of various N-heterocyclic substituted piperazine versions of 5/7-{[2-(4-aryl-piperazin-1-yl)-ethyl]-propyl-amino}-5,6,7,8-tetrahydro-naphthalen-2-ol: effect on affinity and selectivity for dopamine D3 receptorDennis A Brown, Manoj Mishra, Suhong Zhang, et al.
Journal of Medicinal Chemistry|October 1, 2004
Further structurally constrained analogues of cis-(6-benzhydrylpiperidin-3-yl)benzylamine with elucidation of bioactive conformation: discovery of 1,4-diazabicyclo[3.3.1]nonane derivatives and evaluation of their biological properties for the monoamine transportersRohit Kolhatkar, Charles D Cook, Sujit K Ghorai, et al.
Science (New York, N.Y.)|August 11, 2007
LeuT-desipramine structure reveals how antidepressants block neurotransmitter reuptakeZheng Zhou, Juan Zhen, Nathan K Karpowich, et al.
The Journal of Pharmacology and Experimental Therapeutics|August 16, 2018
Tamoxifen Directly Interacts with the Dopamine TransporterSarah R Mikelman, Bipasha Guptaroy, Kyle C Schmitt, et al.
Journal of Neurochemistry|June 22, 2011
SKF-83566, a D1-dopamine receptor antagonist, inhibits the dopamine transporterMelissa A Stouffer, Solav Ali, Maarten E A Reith, et al.
Neurochemical Research|January 1, 2016
Efficacy of Hybrid Tetrahydrobenzo[d]thiazole Based Aryl Piperazines D-264 and D-301 at D₂ and D₃ ReceptorsJuan Zhen, Tamara Antonio, Joanna C Jacob, et al.
Journal of Neurochemistry|August 9, 2020
SLC6 transporter oligomerizationKumaresan Jayaraman, Anand K Das, Dino Luethi, et al.
Cytometry|January 1, 1992
Comparison between flow cytometry and image cytometry in ploidy distribution assessments in gynecologic cancerJ Kaern, J Wetteland, C G Tropé, et al.
Molecular Psychiatry|October 15, 2021
The dopamine transporter gene SLC6A3: multidisease risksMaarten E A Reith, Sandhya Kortagere, Corinde E Wiers, et al.
Pageof 24